mitomycin has been researched along with ethoglucid in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (78.57) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crawford, ED; Thrasher, JB | 1 |
| Abels, J; Hagemeyer, A; Kurth, KH; Sonneveld, P | 1 |
| King, M; Trybula, M | 1 |
| Groos, E; Masters, JR | 1 |
| Groos, E; Masters, JR; Walker, L | 1 |
| English, PJ; Hepburn, PJ; Masters, JR; Parris, CN; Walker, MC | 1 |
| Chisholm, GD; Elton, RA; Hargreave, TB; Newsam, JE; Smith, G | 1 |
| English, P; Masters, JR; Newman, B; Parris, CN; Riddle, P; Walker, MC | 1 |
| Smith, PH | 2 |
| Lum, BL | 1 |
| Koontz, WW | 1 |
| Lum, BL; Torti, FM | 1 |
| Duque, JL; Loughlin, KR | 1 |
4 review(s) available for mitomycin and ethoglucid
| Article | Year |
|---|---|
Complications of intravesical chemotherapy.
Topics: Administration, Intravesical; Antineoplastic Agents; Carcinoma, Transitional Cell; Doxorubicin; Epirubicin; Ethoglucid; Humans; Mitomycin; Mitoxantrone; Thiotepa; Urinary Bladder Neoplasms | 1992 |
Intravesical chemotherapy of superficial bladder cancer.
Topics: Absorption; Animals; Antineoplastic Agents; BCG Vaccine; Carcinoma in Situ; Doxorubicin; Endoscopy; Ethoglucid; Humans; Hydrogen-Ion Concentration; Mitomycin; Mitomycins; Molecular Weight; Neoplasm Recurrence, Local; Teniposide; Thiotepa; Urinary Bladder Neoplasms | 1983 |
The biology and treatment of superficial bladder cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; BCG Vaccine; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Combined Modality Therapy; Cystoscopy; Doxorubicin; Ethoglucid; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Prognosis; Teniposide; Thiotepa; Urinary Bladder; Urinary Bladder Neoplasms | 1984 |
An overview of the treatment of superficial bladder cancer. Intravesical chemotherapy.
Topics: Administration, Intravesical; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Epirubicin; Ethoglucid; Humans; Immunotherapy; Mitomycin; Thiotepa; Urinary Bladder Neoplasms | 2000 |
2 trial(s) available for mitomycin and ethoglucid
| Article | Year |
|---|---|
Intravesical chemotherapy for superficial bladder cancer.
Topics: BCG Vaccine; Carcinoma, Transitional Cell; Clinical Trials as Topic; Doxorubicin; Ethoglucid; Follow-Up Studies; Humans; Mitomycin; Mitomycins; Thiotepa; Urinary Bladder Neoplasms | 1984 |
Clinical trials in superficial and invasive bladder cancer.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Ethoglucid; Humans; Methotrexate; Mitomycin; Mitomycins; Thiotepa; Urinary Bladder Neoplasms | 1984 |
8 other study(ies) available for mitomycin and ethoglucid
| Article | Year |
|---|---|
Secondary hematologic neoplasm after intravesical chemotherapy for superficial bladder carcinoma.
Topics: Aged; Antineoplastic Agents; Doxorubicin; Ethoglucid; Female; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitomycin; Mitomycins; Urinary Bladder Neoplasms | 1990 |
Superficial bladder cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Carcinoma, Papillary; Doxorubicin; Ethoglucid; Female; Humans; Interferons; Mitomycin; Mitomycins; Prognosis; Retinoids; Thiotepa; Urinary Bladder Neoplasms | 1985 |
Intravesical chemotherapy: studies on the relationship between osmolality and cytotoxicity.
Topics: Antineoplastic Agents; Carcinoma, Transitional Cell; Cell Line; Cisplatin; Colony-Forming Units Assay; Doxorubicin; Epirubicin; Ethoglucid; Humans; In Vitro Techniques; Mitomycin; Mitomycins; Osmolar Concentration; Stereoisomerism; Thiotepa; Tumor Stem Cell Assay; Urinary Bladder Neoplasms | 1986 |
Intravesical chemotherapy. Studies on the relationship between pH and cytotoxicity.
Topics: Antineoplastic Agents; Carcinoma, Transitional Cell; Cell Line; Cisplatin; Doxorubicin; Epirubicin; Ethoglucid; Humans; Hydrogen-Ion Concentration; Mitomycin; Mitomycins; Thiotepa; Tumor Stem Cell Assay; Urinary Bladder Neoplasms | 1986 |
Intravesical chemotherapy: in vitro studies on the relationship between dose and cytotoxicity.
Topics: Antineoplastic Agents; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; Ethoglucid; Humans; Injections; Mitomycin; Mitomycins; Thiotepa; Time Factors; Tumor Stem Cell Assay; Urinary Bladder; Urinary Bladder Neoplasms | 1986 |
Superficial bladder cancer: intravesical chemotherapy and tumour progression to muscle invasion or metastases.
Topics: Administration, Intravesical; Carcinoma, Transitional Cell; Ethoglucid; Humans; Methotrexate; Mitomycin; Mitomycins; Neoplasm Invasiveness; Neoplasm Metastasis; Prognosis; Urinary Bladder Neoplasms | 1986 |
Intravesical chemotherapy: combination with Tween 80 increases cytotoxicity in vitro.
Topics: Administration, Intravesical; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Colony-Forming Units Assay; Doxorubicin; Ethoglucid; Humans; In Vitro Techniques; Mitomycin; Mitomycins; Polysorbates; Thiotepa; Urinary Bladder Neoplasms | 1987 |
Intravesical chemotherapy--frequency of instillation.
Topics: Antineoplastic Agents; Doxorubicin; Drug Administration Schedule; Ethoglucid; Humans; Mitomycin; Mitomycins; Thiotepa; Urinary Bladder Neoplasms | 1985 |